Adam Mostafa

Adam Mostafa is an accomplished financial executive with significant experience in leadership roles across various companies in the biotechnology and finance sectors. Currently serving as the Chief Financial Officer at Sitryx since September 2025, Adam is also a Board Member and Chair of the Audit Committee at Satellos Bioscience Inc. and Precision Biologics, Inc. Adam has held a Senior Advisor position at Cumberland Pharmaceuticals since January 2017 and previously served as Chief Financial Officer at X4 Pharmaceuticals and Abpro. Earlier career highlights include managing directorial responsibilities at Cantor Fitzgerald and investment banking roles at Needham & Company and CRT Capital Group. Adam holds a Bachelor's Degree in Economics from Brown University, earned between 1997 and 2001.